コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 detection of novel protein adducts (e.g. by mass spectroscopy).
2 Trapped proteins were identified by mass spectroscopy.
3 artners of Cox4 by affinity purification and mass spectroscopy.
4 opic methods and deuterium-hydrogen exchange mass spectroscopy.
5 oncogene mutation screening was performed by mass spectroscopy.
6 Serum acrolein levels were estimated with mass spectroscopy.
7 haracterized through electrospray ionization mass spectroscopy.
8 d laser desorption ionization time-of-flight mass spectroscopy.
9 arated and detected using gas chromatography/mass spectroscopy.
10 teins and chromatin-associated factors using mass spectroscopy.
11 entified by a combination of proteolysis and mass spectroscopy.
12 ins using analytical ultracentrifugation and mass spectroscopy.
13 a selective vitamin D derivatizing agent and mass spectroscopy.
14 using thermal desorption-gas chromatography-mass spectroscopy.
15 14, 28, 35, and 50 by liquid chromatography-mass spectroscopy.
16 erformed to identify interacting proteins by mass spectroscopy.
17 assayed by natural abundance stable isotope mass spectroscopy.
18 with serum IgE of allergic individuals, and mass spectroscopy.
19 ere characterized by NMR, FT-IR, UV-vis, and mass spectroscopy.
20 rties of the complex using NMR and MALDI-TOF mass spectroscopy.
21 matrix-assisted laser desorption ionization mass spectroscopy.
22 ninfected cells were comparatively mapped by mass spectroscopy.
23 y high-resolution inductively coupled plasma mass spectroscopy.
24 ged cataract human lenses were identified by mass spectroscopy.
25 cleavage and to confirm the cleavage site by mass spectroscopy.
26 it liver membranes and identified as NPC1 by mass spectroscopy.
27 ectroscopic methods including NMR, FTIR, and mass spectroscopy.
28 x RNA helicase CshA (NWMN_1985 or SA1885) by mass spectroscopy.
29 tension products are quantified by MALDI-TOF mass spectroscopy.
30 d laser desorption/ionization time-of-flight mass spectroscopy.
31 Bile acid composition was analyzed by mass spectroscopy.
32 e electronic and emission spectroscopy), and mass spectroscopy.
33 isobaric tagging reagents (iTRAQ) and tandem mass spectroscopy.
34 ere studied using co-immunoprecipitation and mass spectroscopy.
35 ification-specific synuclein antibodies, and mass spectroscopy.
36 rption/ionization time-of-flight (MALDI-TOF) mass spectroscopy.
37 identified potential signaling molecules by mass spectroscopy.
38 yzed for 13C content by using stable-isotope mass spectroscopy.
39 content was measured by ion-coupled plasmon mass spectroscopy.
40 ing gas and liquid chromatography coupled to mass spectroscopy.
41 mapimod using ATP-desthiobiotin pulldown and mass spectroscopy.
42 d laser desorption ionization time of flight mass spectroscopy.
43 y high-performance liquid chromatography and mass spectroscopy.
44 in blood by liquid chromatography and tandem mass spectroscopy.
45 lid Phase Microextraction-Gas Chromatography/Mass Spectroscopy.
46 followed by PCR and electrospray ionization mass spectroscopy.
47 fluorescence in situ hybridization tests or mass spectroscopy.
48 o-high-performance liquid chromatography and mass spectroscopy.
49 ons determined by inductively coupled plasma mass spectroscopy.
50 analyze these foods using gas chromatography-mass spectroscopy.
51 ithiaporphyrin macrocycles were confirmed by mass spectroscopy, 1D and 2D NMR spectroscopy, and X-ray
52 peptide ligands that we sequenced by tandem mass spectroscopy, 5 were previously eluted from HLA cla
53 2)C), i.e., in the same order as accelerator mass spectroscopy, achieved with a relatively inexpensiv
59 hromatography-electrospray ionization-tandem mass spectroscopy analyses, 15 proteins were identified
61 Abl-mediated nmMLCK phosphorylation sites by mass spectroscopy analysis (including Y231, Y464, Y556,
64 tography of the MW2 supernatant, followed by mass spectroscopy analysis of corresponding peaks, we id
69 hort-read-length DNA sequencing coupled with mass spectroscopy analysis of SNPs to study the molecula
70 High-performance liquid chromatography and mass spectroscopy analysis revealed that SleB is require
73 ied N525, a site that cannot be recovered by mass spectroscopy analysis, as a glycosylation site.
75 baseline samples using liquid chromatography-mass spectroscopy and a 2-site immunoassay, respectively
79 lution crystallographic data with structural mass spectroscopy and electron microscopic data to deriv
80 pH anion exchange chromatography, MALDI-TOF mass spectroscopy and FACS analysis with the plant lecti
81 igh performance liquid chromatography-tandem mass spectroscopy and gas chromatography-mass spectrosco
83 ed during human infection were identified by mass spectroscopy and included both previously described
84 ctroscopy and by fast atom bombardment (FAB) mass spectroscopy and it is shown that rapid exchange eq
85 n the supernate of activated platelets using mass spectroscopy and looking for proteins originating f
86 I-06 by an integrated approach using imaging mass spectroscopy and molecular networking, as well as c
87 Activity-guided fractionation, followed by mass spectroscopy and NMR analysis, resulted in the iden
89 romatography (HPLC) and identified by tandem mass spectroscopy and proton nuclear magnetic resonance
90 chromatography, UV-visible spectroscopy, and mass spectroscopy and proved to be uroporphomethene, a c
91 icroextraction coupled to gas chromatography/mass spectroscopy and the determination of conventional
93 djacent cysteine-366 thiol was was proved by mass spectroscopy and X-ray crystal structure studies.
94 cterized using both structural methods (NMR, mass spectroscopy) and photophysical measurements (UV-vi
95 TPD-MS (temperature-programmed decomposition-mass spectroscopy), and TGA-DSC (thermogravimetric analy
96 d laser desorption ionization time-of-flight-mass spectroscopy, and algorithmic means were employed t
97 xchange in the bulk solution, including NMR, mass spectroscopy, and Fourier transform infrared spectr
98 vitro and in vivo phosphorylation analysis, mass spectroscopy, and functional assays to identify two
99 TNFalpha-treated extracts was identified by mass spectroscopy, and its amino-terminal cleavage site
100 sure liquid chromatography, characterized by mass spectroscopy, and subjected to kinetic analysis aga
101 actions through photoaffinity, cross-linking/mass spectroscopy, and X-ray crystallographic studies.
105 y uses a chiral liquid chromatography-tandem mass spectroscopy approach (LC-MS/MS) to quantify each s
108 stablished by nuclear magnetic resonance and mass spectroscopy as a heretofore unidentified alpha,bet
109 f F. nucleatum ATCC 23726 and identified via mass spectroscopy as members of the outer membrane famil
110 vo, and the target antigen was identified by mass spectroscopy as the alpha2 subunit of the alpha2bet
112 trates, we used liquid chromatography tandem mass spectroscopy based sequencing to generate a complet
113 tation profiling was performed by using both mass spectroscopy-based genotyping and Sanger sequencing
116 To identify a repressor protein, we used a mass spectroscopy-based RNA-protein interaction system a
119 Conventional approaches such as ELISA and mass spectroscopy cannot satisfy the needs of continual
120 but worse than continuous flow-isotope ratio mass spectroscopy (CF-IRMS) methods owing to memory effe
121 Furthermore, liquid chromatography/tandem mass spectroscopy characterized 3 distinct types of post
122 layer chromatography and gas chromatography mass spectroscopy confirm that the intact molecule is se
123 ectroscopy and nanometer-scale secondary ion mass spectroscopy confirm the carbon-nitrogen species in
124 de gel electrophoresis followed by MALDI/TOF mass spectroscopy confirmed high expression of beta-acti
126 ers or pH inactivation of peroxynitrite, and mass spectroscopy confirmed nitration of conserved tyros
128 f metal uptake by inductively coupled plasma mass spectroscopy demonstrated that ZIPB is selective fo
132 e utilized amide hydrogen/deuterium exchange mass spectroscopy (DXMS) to assess potential conformatio
135 R), fluorescence quenching, and electrospray mass spectroscopy (ESI-MS) were implemented to examine t
136 lity of using electrospray ionisation tandem mass spectroscopy (ESI-MS/MS) to unequivocally determine
137 ption energies of radicals detected from our mass-spectroscopy experiment provide an in-depth underst
138 found that high-throughput affinity capture-mass spectroscopy experiments can detect functional inte
140 the trapped substrate proteins identified by mass spectroscopy, five proteins, cathepsin G, glutaredo
142 ant species by the use of gas chromatography-mass spectroscopy, followed by detailed data mining and
143 nts, and then subjected selected antigens to mass spectroscopy for amino acid sequencing for comparis
144 n spectroscopy or inductively coupled plasma mass spectroscopy for total Se and X-ray absorption spec
147 ic pollutants measured by gas chromatography-mass spectroscopy (GC-MS); all have theoretical and prac
150 on spectroscopy (XPS) and gas-chromatography/mass spectroscopy (GC/MS), this attachment strategy is d
153 Calibrated fluorescent images combined with mass spectroscopy give a transport rate of 0.06 ASP+/hNE
154 d laser desorption ionization time-of-flight mass spectroscopy (GPC-MALDI ToF MS), which revealed the
156 AF4) coupled with inductively coupled plasma mass spectroscopy (ICP-MS) for the speciation and quanti
158 quantified using inductively coupled plasma mass spectroscopy (ICPMS) and migration was found to occ
159 (AHG) interface to inductive coupled plasma mass spectroscopy (ICPMS) was developed for measuring ar
160 uantitatively via inductively coupled plasma mass spectroscopy (ICPMS), allowing for direct compariso
167 d chromatography and electrospray ionization mass spectroscopy identified selective accumulation of p
168 g ERK-dependent phosphorylation at Ser(319), mass spectroscopy identified two other ERK-phosphorylate
169 blotting and proteomic analyses using 2D-gel/mass spectroscopy identified vimentin and beta-catenin a
170 this issue, a correlative analysis combining mass spectroscopy imaging (MSI) and fluorescence imaging
172 al lipid surveys using liquid chromatography-mass spectroscopy in nondiabetic, lean, predominantly no
173 emicals executed by using gas chromatography-mass spectroscopy in order to correlate the bioactivitie
174 sis followed by liquid chromatography tandem mass spectroscopy, including those involved in metabolis
177 ffers a cheaper alternative to isotope-ratio mass spectroscopy (IRMS), but its use in studying plant
180 ase liquid chromatography (LC) with ion trap mass spectroscopy (IT-MS), using positive polarity atmos
181 Using reverse phase HPLC and electrospray mass spectroscopy, it was determined that oligonucleotid
183 ment of proteins using liquid chromatography-mass spectroscopy (LC-MS) analyses and does not necessar
186 matography (HPLC), and liquid chromatography-mass spectroscopy (LC-MS) pteridine urinalyses among oth
188 pin ferric 2B4; liquid chromatography-tandem mass spectroscopy (LC-MS/MS) analysis shows that in this
190 igh performance liquid chromatography tandem mass spectroscopy (LC/MS-MS) on plasma, urine, and lung
191 A4H aminopeptidase activity were detected by mass spectroscopy, LTA4H amounts were detected by ELISA,
194 lished mouse model and liquid chromatography-mass spectroscopy/mass spectroscopy-based lipidomics.
195 ce acceptors is analyzed using secondary ion mass spectroscopy measurements and traced to thermal acc
199 ique liquid chromatography-mass spectrometry/mass spectroscopy method quantifying circulating and equ
203 ontent cell screening, expression profiling, mass spectroscopy, mouse models of disease, and a post-l
204 Fourier transform spectroscopy (DRIFT), and mass spectroscopy (MS) analysis of RhAl2O3 catalyst unde
205 CV sT FLAG-affinity purification followed by mass spectroscopy (MS) analysis, which identified severa
206 rhodopsin chromophore was determined by HPLC-mass spectroscopy (MS) and the spectral properties by sp
209 oassays (ELISA and RIA), or various types of mass spectroscopy (MS)-based protocols, semi-quantitativ
210 ment of the osmium moiety is demonstrated by mass spectroscopy (MS-MALDI-TOF) and cyclic voltammetry.
211 orous microarrays and their combination with Mass-Spectroscopy (MS) techniques, to protein properties
213 matrix-assisted laser desorption/ionization mass spectroscopy, N-terminal sequencing, and improved c
215 e often prepared for nanoscale secondary ion mass spectroscopy (NanoSIMS) investigations by depositin
222 teins experimentally elucidated by proteomic mass spectroscopy of signalling complexes and proteins b
226 tion magic angle spinning magnetic resonance mass spectroscopy on endometrial cancer surgical specime
230 ions by optical microscopy and secondary ion mass spectroscopy reveal that Ca is concentrated along t
232 d laser desorption/ionization time-of-flight mass spectroscopy revealed abnormal expression of a clus
233 from rodent ventricular lysates followed by mass spectroscopy revealed an interaction with junctophi
237 bitor screen, and a kinase trapping-Orbitrap mass spectroscopy screen to systematically identify esse
239 Analysis of the phosphotyrosine proteome by mass spectroscopy showed differential phosphorylation am
240 es by high performance liquid chromatography/mass spectroscopy showed that treatment with imatinib in
244 s lower than the corresponding secondary ion mass spectroscopy (SIMS) signal, the mass spectra are si
245 ram quantities and fully characterized using mass spectroscopy, size exclusion chromatography (SEC),
247 , we use single particle inductively coupled mass spectroscopy (SP-ICP-MS) to measure directly NP dia
248 e single particle-inductively coupled plasma mass spectroscopy (SP-ICPMS) to help quantify exposure t
249 , single-particle inductively coupled plasma mass spectroscopy (spICP-MS) with two different plant di
250 two-dimensional liquid chromatography-tandem mass spectroscopy strategy and functional network analys
253 refined a derivatization gas chromatography-mass spectroscopy technique to measure 11 mono- and dica
255 ng pathways in human urothelial cells, using mass spectroscopy techniques, an agonist-dependent inter
258 such as nucleic acid amplification tests and mass spectroscopy that allow clinical laboratories to de
259 o-dimensional gel electrophoresis (2DIGE) or mass spectroscopy that represent unbiased approaches (as
260 ow, using electronic spectroscopy, HPLC, and mass spectroscopy, that in W191F partial formation of a
262 chromatography with electrospray-ionization mass spectroscopy, the first step of this transformation
264 eric matrix protein (COMP) and confirmed, by mass spectroscopy, the presence of deamidated (Asp(64))
265 rystallography, NMR, terahertz spectroscopy, mass spectroscopy, thermodynamics, and computer simulati
267 dem mass spectroscopy and gas chromatography-mass spectroscopy to discriminate global metabolites pro
268 nd electrospray ionization-Fourier transform mass spectroscopy to follow the loading of the activated
269 odies in a far-Western technique followed by mass spectroscopy to identify the C3b acceptor molecule(
271 scopy (XPS) and time-of-flight secondary ion mass spectroscopy (TOF-SIMS) are used to confirm sample
272 r, we performed time-of-flight secondary-ion mass spectroscopy (ToF-SIMS) measurements for quench-coo
273 hniques, namely time-of-flight secondary ion mass spectroscopy (ToF-SIMS), atom probe tomography (APT
274 A/TGA) and temperature programmed desorption-mass spectroscopy (TPD-MS) in combination with X-ray dif
281 mor-bearing mice, inductively coupled plasma mass spectroscopy was used to quantitatively and orthogo
284 advances and increased availability of lipid mass spectroscopy, we are now starting to discern the pa
285 tive integrated liquid chromatography-tandem mass spectroscopy, we characterize methylation of (i) re
288 Using co-immunoprecipitation and tandem mass spectroscopy, we found that HIV1 Vpr engages a DDB1
294 ing NMR and liquid chromatography coupled to mass spectroscopy, we identified the main compatible sol
295 d laser desorption/ionization time-of-flight mass spectroscopy, we identified, out of the 100 cystein
296 h the use of the technique of time-of-flight mass spectroscopy, we obtain strong-field ionization yie
299 ption spectroscopy and liquid chromatography-mass spectroscopy, which showed that the Se-tolerant mot
300 et-associated protein from the PAT family by mass spectroscopy, which was further confirmed by immuno
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。